3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Classical hematology
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Lymphoma
14
Leukemia, Myeloid, Acute
12
Leukemia
11
Myelodysplastic Syndromes
9
Leukemia, Lymphocytic, Chronic, B-Cell
8
Lymphoma, Non-Hodgkin
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
7
Leukemia, Biphenotypic, Acute
5
Hodgkin Disease
5
Hematologic Neoplasms
5
Multiple Myeloma
4
Hematologic Diseases
4
Lymphoma, Follicular
3
Leukemia, Myeloid
3
Leukemia, Lymphoid
3
Burkitt Lymphoma
3
Waldenstrom Macroglobulinemia
2
Preleukemia
2
Precancerous Conditions
2
Neoplasms, Plasma Cell
2
Neoplasms by Histologic Type
2
Neoplasms
2
Myeloproliferative Disorders
2
Lymphoproliferative Disorders
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell, Marginal Zone
2
Lymphatic Diseases
2
Leukemia, B-Cell
2
Interventions
fludarabine phosphate
3
Cyclophosphamide
3
Whole-Body Irradiation
2
Thiotepa
2
Melphalan
2
Busulfan
2
Alemtuzumab
2
AP 1903 reagent
2
fludarabine
1
Tacrolimus
1
Range of Motion, Articular
1
Peripheral Blood Stem Cell Transplantation
1
Methylprednisolone Hemisuccinate
1
Methylprednisolone
1
Bone Marrow Transplantation
1
Antilymphocyte Serum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Anemia, Sickle Cell
×
Bone Marrow Transplantation
×
Lymphoid
×
Clear all
NCT07145411
2025-08-28
HOPE
Ossium Health, Inc.
Recruiting
10 enrolled